Last reviewed · How we verify
Glioma, malignant
Approved treatments
- Gliadel · Avet Lifesciences
Gliadel works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and grow. - Temodal · Armando Santoro, MD
- Carmustin · University Hospital Freiburg
- Temodar · Merck & Co.
Temodar works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Glioma, malignant patent landscape — cliff calendar, originator estates, attackable patents
- Glioma, malignant treatment landscape brief
- Glioma, malignant treatment updates RSS
Frequently asked questions about Glioma, malignant
What drugs treat Glioma, malignant?
Tracked treatments include Gliadel, Temodal, Carmustin, Temodar.
What is the treatment for Glioma, malignant?
Standard treatment for Glioma, malignant includes Gliadel, Temodal, Carmustin, Temodar. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Glioma, malignant patent cliff · Glioma, malignant CI report
- Treatment: Gliadel · Avet Lifesciences
- Treatment: Temodal · Armando Santoro, MD
- Treatment: Carmustin · University Hospital Freiburg
- Treatment: Temodar · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing